/ Kills / RECOVERY KILL
RECOVERY KILL
“Heal like you borrowed the body.”
// 01
Summary.
The flagship. Also known in the forum as Wolverine. Body-wide tissue repair — tendon, ligament, cartilage, skin, gut. BPC-157 + TB-500 is the classic stack. We add GHK-Cu for connective tissue remodeling and microvascular support.
BPC-157 is a 15-amino-acid peptide fragment derived from a gastric protective protein. TB-500 is a synthetic analog of thymosin beta-4. Together they are the most-cited tissue-repair stack in the peptide forums for a reason — healing is systemic rather than site-local. GHK-Cu is a copper-binding tripeptide that upregulates collagen remodeling and dermal repair. Stacking the three gets you deep tissue, connective tissue, and skin in one cycle.
// 02
The stack.
Peptide · 01
BPC-157
Body Protection Compound
Systemic tissue repair — tendon, ligament, nerve, gut, vascular.
typical 10 mg / vial
Peptide · 02
TB-500
Synthetic Thymosin β-4 fragment
Cell migration, angiogenesis, inflammation modulation.
typical 10 mg / vial
Peptide · 03
GHK-Cu
Copper tripeptide
Collagen remodeling, wound healing, dermal and connective support.
50 mg / vial · topical + SubQ
// 03
Reconstitution.
Kitchen-counter math. No research-paper microgram arithmetic. U-100 insulin syringes, standard bacteriostatic water.
10 mg BPC-157 + 10 mg TB-500 — pre-mixed, one vial.
Add 3 mL bacteriostatic water. Swirl, don't shake.
Refrigerate after reconstitution.
10–20 units M–F subcutaneously (insulin syringe, U-100).
· 10 units ≈ 333 mcg BPC-157 + 333 mcg TB-500
· 15 units ≈ 500 mcg BPC-157 + 500 mcg TB-500
· 20 units ≈ 667 mcg BPC-157 + 667 mcg TB-500
GHK-Cu · 50 mg vial, add 5 mL bac water.
· 1 mg SubQ daily = 10 units
· or apply topically post-shower (serum)
Rotate injection sites. Abdomen, flank, upper outer thigh. Alcohol prep. Dispose sharps properly.
// 04
Dosing table.
// 05
Cycle & timing.
ON
4–8 WEEKS
Weekends off. Run longer for post-surgical rehab or chronic injury — always with imaging check-in.
OFF
4–8 WEEKS
Most forum reports show the off-cycle is where consolidation shows up on MRI / functional testing.
// 06
Contraindications.
- —Active malignancy. Angiogenic peptides are a hard stop until oncology clears.
- —Pregnancy / lactation. No data. Don't.
- —Active bleeding or pre-op. Stop 2 weeks before elective surgery.
- —Known copper sensitivity (GHK-Cu).
- —If you have questions, talk to a licensed physician before starting.
// 07
Evidence.
PRECLINICAL
Rat / rabbit tendon and ligament studies on BPC-157 since the 1990s. Consistent accelerated-healing signal. TB-500 has analogous cell-migration literature.
HUMAN
Human data remains sparse and mostly anecdotal. This is exactly why the IRB registry exists — real-world data, structured.
GHK-Cu
Copper-peptide data in dermatology and wound healing spans 40+ years. Well-characterized mechanism of action on collagen type I/III.
// 08
Community polls.
DID IT WORK FOR YOU?
- MEANINGFUL IMPROVEMENT71%
- MINOR IMPROVEMENT21%
- NO CHANGE6%
- GOT WORSE2%
n = 412 · last 12 months · self-reported · self-reported, self-selected. Not a controlled trial.
HOW DID YOU DOSE?
- STD · 15 UNITS M–F58%
- HEAVY · 20 UNITS M–F24%
- LIGHT · 10 UNITS14%
- OTHER4%
n = 412 · self-reported, self-selected. Not a controlled trial.
// 09
Adverse events.
MILD (INJ SITE)
38
MODERATE (GI / HEADACHE)
11
SEVERE
0
// 10
Related kills.
SLEEP KILL
“Die better at night.”
FAT KILL
“Not a diet. A vendetta.”
LONGEVITY KILL
“Outlive your enemies.”
// Disclaimer
Nothing on killer.health is medical advice. This platform is a research registry and information aggregator. Content is drawn from peer-reviewed publications, clinical protocols and community sources. killer.health does not endorse any compound, supplier or treatment. Always work with a licensed physician inside an established clinical relationship before starting, stopping or modifying any protocol. Data capture is governed by IRB PPRN-001-2025. Anonymous submissions are the default.